Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment

by Elizabeth A. Comen, Robert L. Bowman, Robert L. Bowman, Maria Kleppe, Maria Kleppe
Published 2018-06-01

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

by Jennifer D. Brooks, Elizabeth A. Comen, Anne S. Reiner, Irene Orlow, Siok F. Leong, Xiaolin Liang, Lene Mellemkjær, Julia A. Knight, Charles F. Lynch, Esther M. John, Leslie Bernstein, Meghan Woods, David R. Doody, The WECARE Study collaborative group, Kathleen E. Malone, Jonine L. Bernstein
Published 2018-12-01